Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-30

Clinical Trial Update: Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules [Phase 4]

View source ↗

Summary

Phase 4 human factors study assessing the user interface of TOBI Podhaler with placebo capsules; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBI Podhaler (tobramycin inhalation powder)

Snippet

Sponsor: Mylan Inc. | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2020-06-30